The AMA and more than 70 other organizations are conducting a comprehensive multi-specialty survey of America’s physician practices. The results will be used to positively influence national decision makers to ensure accurate and fair representation for all physicians and patients, and to articulate the challenges of running a practice that provides expert patient care, while operating a business that is sustainable. Of particular importance is the section of the study pertaining to practice expenses and the amounts that are attributable to you. The Centers for Medicare & Medicaid Services has indicated it will use the results of this study to help determine physician payment. The survey firm, dmrkynetec, will contact randomly selected physicians and practice managers to collect responses. All responses will remain confidential.
As of May 23, Medicare FFS will require and send NPI-Only in ALL provider identifier fields for all HIPAA and paper transactions where a provider identifier is required. If you send Medicare a transaction with a Medicare legacy identifier in any of the provider fields, your claim will be rejected. These transactions include all electronic and paper claims (837I, 837P, NCPDP, DDE and paper CMS-1500 and UB-04), the 276/277 claims status transaction, the 270/271 eligibility transaction, 835 remittance advice and SPR paper remittance.
Postoperative pain in children with cancer can be safely managed with simultaneous epidural and intravenous opioids, according to researchers at St. Jude Children's Research Hospital in Memphis, Tennessee.
ASA Member Peter J. Pronovost, M.D., Ph.D., professor of anesthesiology, critical care and surgery in the Johns Hopkins University School of Medicine has been named to this year’s Time magazine 100 most influential people.
The AMA and more than 70 other organizations are conducting a comprehensive multi-specialty survey of America’s physician practices. The results will be used to positively influence national decision makers to ensure accurate and fair representation for all physicians and patients, and to articulate the challenges of running a practice that provides expert patient care, while operating a business that is sustainable.
On Wednesday, April 16, 2008, the U.S. Supreme Court issued an opinion affirming the Kentucky State Supreme Court’s opinion that Kentucky’s lethal injection protocol does not violate the Eighth Amendment’s ban on cruel and unusual punishment.
In diabetic patients undergoing medical management of foot osteomyelitis, bone culture-based antibiotic therapy improves the chances of successful treatment, according to findings published in the April issue of Diabetes Care.
"The question of surgical versus nonsurgical treatment for diabetic patients with osteomyelitis of the foot remains subject to debate," Dr. Eric Senneville, of Dron Hospital, Tourcoing, France, and colleagues write. They add, "It was traditionally thought that these infections could not be treated without resecting the infected bone."
Combining low-dose difluoromethylornithine (DFMO) and the nonsteroidal anti-inflammatory drug (NSAID) sulindac lowers the risk for recurrent colorectal adenomas.
The results of the phase 3 randomized trial, which were reported here at the American Association for Cancer Research 2008 Annual Meeting, showed that among patients who received the active drug combination, there was a 70% decrease in all adenomas and a 92% reduction in advanced adenomas. A 95% reduction in multiple adenomas was also observed.